Author:
Gabrielson Andrew,Tesfaye Anteneh A.,Marshall John L.,Pishvaian Michael J.,Smaglo Brandon,Jha Reena,Dorsch-Vogel Karen,Wang Hongkun,He Aiwu Ruth
Funder
American Cancer Society
The Ruesch Center for the Cure of Gastrointestinal Cancers
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907–1917
2. Tang Z-Y, Zhou X-D, Ma Z-C, Wu Z-Q, Fan J, Yang B-H (1998) Multimodality treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 13(11-s4):S315–S319
3. Llovet JM et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378
4. Roberts LR (2008) Sorafenib in liver cancer: just the beginning. N Engl J Med 359:420
5. Manghisi Giuseppe, Elba Silvana, Mossa Ascanio, Giorgio Antonio, Aloisio Vincenza, Perrotta Anna et al (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751–755
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献